US-approved vaccines effective against B1617 variant of Covid-19: US health official

WHO classified the B1617 SARS-CoV-2 variant, and confirmed that the variant was first detected in India

Comments

Popular posts from this blog

‘No difference between Congress, PFI’: Karnataka BJP

2 Mangaluru businessmen in Saudi to fly 167 home